The cardiovascular data technology developer has launched with $54m in funding, $43m coming from a Cigna Ventures-backed series B round.
Cleerly, a US-based developer of machine learning algorithms for heart disease detection, received $43m yesterday in a series B round featuring Cigna Ventures, the corporate venturing arm of healthcare services provider Cigna. The round was led by venture capital firm Vensana Capital and included LRVHealth, New Leaf Venture Partners, DigiTx Partners and American College of…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.